A61K 2039/645
Dendrimers
Official title: {Dendrimers; Multiple antigen peptides}
A61K2039/645 (Dendrimers) appears on 154 US grants and 269 published applications in this corpus.
Search patents in A61K- Granted patents
- 154
- Published applications
- 269
- Assignees
- 164
- Inventors
- 567
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 3 | 1 |
| 2002 | 1 | 0 |
| 2003 | 1 | 1 |
| 2004 | 2 | 5 |
| 2005 | 0 | 7 |
| 2006 | 3 | 10 |
| 2007 | 1 | 10 |
| 2008 | 3 | 4 |
| 2009 | 8 | 5 |
| 2010 | 3 | 8 |
| 2011 | 1 | 10 |
| 2012 | 3 | 8 |
| 2013 | 2 | 5 |
| 2014 | 6 | 9 |
| 2015 | 8 | 12 |
| 2016 | 11 | 19 |
| 2017 | 9 | 15 |
| 2018 | 13 | 15 |
| 2019 | 8 | 20 |
| 2020 | 15 | 9 |
| 2021 | 5 | 17 |
| 2022 | 7 | 14 |
| 2023 | 8 | 13 |
| 2024 | 12 | 20 |
| 2025 | 7 | 16 |
| 2026 | 7 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modified envelope protein of human immunodeficiency virus and use thereof4 Aug 2026US 12,697,383 B2Xiamen Innovax Biotech Co., Ltd.
- Multiple antigenic peptide against corona virus and immunostimulating composition containing the same4 Aug 2026US 12,697,384 B2Animal Allergy Clinical Laboratories Inc.
- Multiepitope vaccine for the treatment of ALZHEIMER'S disease23 Jun 2026US 12,661,392 B2Othair Prothena Limited
- Unified platform for rapid production of nanovaccines with enhanced safety, efficacy and precision9 Jun 2026US 12,651,648 B2Santa Clara University
- Multi-antigenic peptide mimics of gonococcal lipo-oligosaccharide (LOS) epitopes19 May 2026US 12,629,410 B2University of Massachusetts
- Rhizavidin variants8 Oct 2026US 2026/0308208 A1Affinivax, Inc.
- Biodegradable scaffolds for enhancing vaccine efficacy24 Sep 2026US 2026/0284184 A1The Regents of the University of California
- Modified biotin-binding protein, fusion proteins thereof and applications10 Sep 2026US 2026/0265313 A1Children's Medical Center Corporation
- Materials and Methods For Cell-Free Expression of Vaccine Epitope Concatemers27 Aug 2026US 2026/0250332 A1Leidos, Inc.
- Influenza neuraminidase tetramers13 Aug 2026US 2026/0234589 A1Icosavax, Inc.
Most cited
By later US patents
- Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof74US 5,580,563 A1996
- Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines55US 7,018,637 B2Aventis Pasteur Limited · 2006
- Adjuvant properties of poly (amidoamine) dendrimers43US 5,795,582 ANovavax, Inc. · 1998
- Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugates37US 5,229,289 AThe Biomembrane Institute · 1993
- Multi oligosaccharide glycoconjugate bacterial meningitis vaccines30US 6,656,472 B1Aventis Pasteur Limited · 2003